Frankfurt , Dec 20, 2014 – German drugmaker Bayer said on Wednesday it had entered into a definitive agreement to sell veterinary products to treat horses to Sanofi’s animal health unit Merial.
The deal to sell these products – Legend/Hyonate and Marquis – is expected to close in the first quarter, subject to merger control clearance, it said, without providing financial details.
“These equine products have no strategic relevance for our business and represent less than 2 percent of our worldwide sales,” said Dirk Ehle, head of Bayer HealthCare’s Animal Health Division. Reuters
By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…
Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…
New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…
National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…
Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…
New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…